Author:
Gettinger Scott,Hellmann Matthew D.,Chow Laura Q.M.,Borghaei Hossein,Antonia Scott,Brahmer Julie R.,Goldman Jonathan W.,Gerber David E.,Juergens Rosalyn A.,Shepherd Frances A.,Laurie Scott A.,Young Tina C.,Li Xuemei,Geese William J.,Rizvi Naiyer
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference28 articles.
1. EGFR mutation incidence in non–small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII);Midha;Am J Cancer Res,2015
2. Inequalities in lung cancer: a world of EGFR;Carbonnaux;Eur Respir J,2016
3. Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update;Hanna;J Clin Oncol,2017
4. Non–small cell lung cancer, version 5.2017;Ettinger;J Natl Compr Canc Netw,2017
5. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009
Cited by
148 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献